Sangamo Therapeutics Inc (NASDAQ:SGMO)
| 3.51 Delayed Data As of Feb 03 |  -0.16 / -4.36%Today’s Change | 2.72 Today|||52-Week Range 6.42 | +11.78% Year-to-Date |
Latest SGMO News | Press Releases
No recent news for Sangamo Therapeutics Inc.
Today’s Trading
| Previous close | 3.67 |
| Today’s open | 3.59 |
| Day’s range | 3.50 - 3.68 |
| Volume | 1,104,840 |
| Average volume (3 months) | 1,329,976 |
| Market cap | $575.2M |
Data as of 3:59pm ET, 02/03/2023
Growth & Valuation
| Earnings growth (last year) | -37.04% |
| Earnings growth (this year) | -5.54% |
| Earnings growth (next 5 years) | -1.00% |
| Revenue growth (last year) | -6.34% |
| P/E ratio | NM |
| Price/Sales | 9.79 |
| Price/Book | 1.36 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NKTRNektar Therapeutics | +0.09 | +3.00% |
| NSTGNanoString Technolog... | -0.49 | -3.90% |
| BNGOBionano Genomics Inc | -0.10 | -5.08% |
| ---- |
Data as of 4:00pm ET, 02/03/2023
Financials
| Next reporting date | March 2, 2023 |
| EPS forecast (this quarter) | -$0.36 |
| Annual revenue (last year) | $110.7M |
| Annual profit (last year) | -$178.3M |
| Net profit margin | -161.05% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Brisbane, California |
Forecasts
